Acute leukemias of ambiguous lineage

Area of Science:

• Hematology
• Oncology
• Immunophenotyping

Background:

• The 2008 WHO Classification introduced
• leukemias of ambiguous lineage
• including mixed phenotype acute leukemia (MPAL).
• MPAL is rare and challenging to diagnose.

Purpose of the Study:

• To define the diagnostic criteria for MPAL.
• To outline the classification and prognostic factors of MPAL.
• To discuss treatment strategies for MPAL.

Main Methods:

• Utilized WHO 2008 classification criteria.
• Employed immunophenotyping for lineage determination (myeloperoxidase, CD19, cytoplasmic CD3).
• Reviewed chromosomal anomalies (BCR-ABL1, MLL gene rearrangements) and subtypes (B/myeloid NOS, T/myeloid NOS, B/T NOS, B/T/myeloid NOS).

Main Results:

• MPAL diagnosis requires evidence of multiple cell lineages.
• Specific genetic abnormalities define subsets of MPAL.
• MPAL exhibits variable response to chemotherapy and generally poor prognosis.

Conclusions:

• MPAL is a distinct category of leukemia requiring extensive immunophenotyping.
• Genetic aberrations and lineage combinations impact MPAL prognosis.
• Allogeneic hematopoietic stem cell transplantation offers the best therapeutic option for MPAL.